David Serreze to B-Cell Activation Factor Receptor
This is a "connection" page, showing publications David Serreze has written about B-Cell Activation Factor Receptor.
Connection Strength
0.145
-
Wang Q, Racine JJ, Ratiu JJ, Wang S, Ettinger R, Wasserfall C, Atkinson MA, Serreze DV. Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy. J Immunol. 2017 12 01; 199(11):3757-3770.
Score: 0.145